Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Patent
1994-12-30
1995-11-14
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
424 945, 424709, 514941, 514942, A61K 4904
Patent
active
054664403
ABSTRACT:
Nanoparticulate crystalline substances formulated with stabilizers and pharmaceutically acceptable clays to enhance contact between the crystalline substances and the gastrointestinal tract. These formulations have improved safety profiles, a low potential for absorption, are not viscous and are not contraindicated for GI perforations or intestinal obstructions. The properties of the surfactant stabilizers are independent of the crystalline drug used and largely determine the extent to which the formulation coats the GI tract.
REFERENCES:
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 4501726 (1985-02-01), Schroder et al.
patent: 4927624 (1990-05-01), Bryant et al.
patent: 5015452 (1991-05-01), Matijevic
patent: 5107842 (1992-04-01), Levene et al.
patent: 5118528 (1992-06-01), Fessi et al.
patent: 5145684 (1982-09-01), Liversidge et al.
patent: 5352434 (1994-10-01), Illig et al.
Cooper Eugene R.
Eickhoff W. Mark
Liversidge Gary
Ruddy Stephen B.
Eastman Kodak Company
Hollinden Gary E.
Rosenstein Arthur H.
LandOfFree
Formulations of oral gastrointestinal diagnostic X-ray contrast does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations of oral gastrointestinal diagnostic X-ray contrast , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations of oral gastrointestinal diagnostic X-ray contrast will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1219148